Microsensor Labs, LLC

Chicago, IL

UEI
ZJR3H843V6U4
CAGE
6WVL8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
33 N Dearborn St #1000, Chicago, IL 60602, USA
Founded
2016
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Microsensor Labs, LLC, a for-profit biotech company based in Chicago, Illinois, develops automated laboratory instrumentation and detection platforms for federal research agencies as a grant recipient under the Small Business Innovation Research (SBIR) Program. The vendor competes exclusively in the federal grant space as a prime recipient, with no federal contract prime awards and no federal contract vehicle seating in the source data. Recent and active grants center on pathogen detection and high-throughput cell sorting technologies, with work funded by the National Institutes of Health, the Centers for Disease Control and Prevention, and the U.S. Department of Agriculture's National Institute of Food and Agriculture.

Microsensor Labs' active grant portfolio spans life sciences and food safety research. The vendor received a $306,872 Project Grant from CDC in September 2026 (CFDA 93.318, running through August 2027) to develop a high-throughput automated platform for rapid isolation and testing of Salmonella, with performance in Illinois. Earlier, the vendor completed an SBIR Phase I award from USDA NIFA (CFDA 10.212, $181,500, awarded September 2025 and completing May 2026) for MagiCyte MB, a fully automated, high-speed detection and enumeration system for Salmonella pathogen isolation that integrates robotics, computer vision, and artificial intelligence to replace manual detection processes. A prior SBIR Fast Track award from the National Institute of General Medical Sciences (April 2022, completing August 2025) funded development of MagiCyte, a high-throughput chip-based magnetic cytometer for single-cell sorting of rare cells including circulating tumor cells, fetal cells, and stem cells at single-cell resolution.

The vendor's customer base clusters within the National Institutes of Health (primarily the National Institute of General Medical Sciences and the National Cancer Institute) and the Department of Health and Human Services, accounting for 67% of recent awards. Combined obligated dollars across nine total awards reach $7.6 million, with activity concentrated in SBIR Phase I and Fast Track grants rather than conventional contract vehicles. Only one award faces ultimate completion within the next twenty-four months, creating minimal near-term recompete pressure. The vendor holds no sub-award relationships and operates entirely as a prime grant recipient, positioning it as a technology-development vehicle rather than a prime contractor or subcontractor in the federal procurement ecosystem.

Quick answers

Is Microsensor Labs, LLC registered in SAM.gov?

Yes. Microsensor Labs, LLC's SAM.gov registration is active through November 26, 2026.

What is Microsensor Labs, LLC's most recent federal award?

Microsensor Labs, LLC's most recent federal grant award is A high-throughput automated platform for rapid isolation and testing of salmonella (R43CK000713), from Office of Financial Resources (CDC), on September 1, 2026.

On GovTribe

See Microsensor Labs, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors